Kantapat Chansaenpak Selected Research

Kantapat Chansaenpak Research Topics

18	Neoplasms (Cancer) 01/2024 - 11/2018
4	Hypoxia (Hypoxemia) 01/2023 - 08/2021
3	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2024
1	Bacterial Infections (Bacterial Infection) 12/2023
1	Adenocarcinoma 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Obesity 01/2020
1	Liver Neoplasms (Liver Cancer) 06/2018

7	azaBDPBA compoundIBA 01/2024 - 11/2018
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2023 - 01/2022
4	Coloring Agents (Dyes)IBA 01/2022 - 11/2018
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022 - 04/2019
2	Indomethacin (Indometacin)FDA LinkGeneric 01/2022 - 01/2021
2	Fluorescent Dyes (Fluorescent Probes)IBA 05/2021 - 11/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2020
1	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 01/2024
1	pyrazoleIBA 12/2023
1	Methotrexate (Mexate)FDA LinkGeneric 01/2023
1	FlavonoidsIBA 01/2023
1	QuercetinIBA 01/2023
1	vanillinIBA 12/2022
1	indoleIBA 12/2022
1	tetramethylene hemicyanineIBA 12/2022
1	monomethoxypolyethylene glycol (MPEG)IBA 09/2022
1	Acetazolamide (Diamox)FDA LinkGeneric 01/2022
1	Carbonic Anhydrase IXIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022
1	Photosensitizing Agents (Photosensitizers)IBA 01/2022
1	AnionsIBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 08/2021
1	diphenyliodoniumIBA 08/2021
1	Chalcone (Benzalacetophenone)IBA 05/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2021
1	coumarinIBA 01/2021
1	Singlet OxygenIBA 01/2021
1	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 01/2020
1	IonsIBA 06/2018
1	FluoridesIBA 06/2018

7	Therapeutics 01/2024 - 01/2020
3	Photothermal Therapy 01/2024 - 09/2022
3	Precision Medicine 01/2023 - 01/2022
2	Photochemotherapy (Photodynamic Therapy) 01/2022 - 01/2022
1	Drug Therapy (Chemotherapy) 01/2023